FIGS, Inc. FIGS

13.42 0.93 7.45% as of 25 Sep
Market cap
$2.1B
P/E
36.3×
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 13.24
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell 2 2 — 2 2 1 2 2 — — — —
Insider Ownership 9.47%

Capital & Financial Ratios

Market Cap 2,070.00
Revenue 710.08
Net Income 61.92
Free Cash Flow 97.22
Net Debt (296.29)
Current Ratio 4.96
Debt/Equity 0.00
P/E ratio 36.27
P/S ratio 3.15
P/B ratio 5.05
Past 5Y EPS Growth 84.83%
This Y EPS Growth 93.42%
Next Y EPS Growth 3.06%
Next 5Y EPS Growth 28.52%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 247 245 301 296
Receivables 7 9 6 23
Inventory 119 116 128 120
Other — — — —
386 383 447 453
2023 2024 2025 Q'26
Payables 15 9 18 9
ST’ Debt — — — —
Other 3 4 4 4
57 90 91 91
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — 19.12% 7.65%
Cash Flow — 22.98% 0.00%
Earnings — (7.20%) 17.36%
Book Value — 34.97% 12.44%

Revenue

Mar Jun Sep Dec Year
’26 160 197 — — —
’25 125 153 152 202 631
’24 119 144 140 152 556
’23 120 138 142 145 546
’22 110 122 129 145 506
’21 87 101 103 129 420
’20 32 64 77 90 263
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (3) 47 — — —
’25 9 (12) 3 61 61
’24 12 17 23 30 81
’23 (3) 29 54 20 101
’22 (8) (19) (13) 5 (35)
’21 16 17 20 14 66
’20 (1) 25 (1) (1) 22
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (6) 44 — — —
’25 8 (14) 1 58 53
’24 11 8 18 27 64
’23 (4) 29 46 14 85
’22 (8) (20) (16) 3 (41)
’21 16 16 19 13 64
’20 (2) 25 (2) (2) 19
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.03 0.15 — — —
’25 0.00 0.04 0.05 0.10 0.19
’24 0.01 0.01 (0.01) 0.01 0.02
’23 0.01 0.02 0.03 0.05 0.12
’22 0.05 0.03 0.02 0.02 0.11
’21 0.07 (0.26) 0.03 0.06 (0.06)
’20 0.03 0.09 0.12 0.07 0.30
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2.1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — — 22.04 5.55 5.16 4.30 3.57

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — — 50.40 27.82 10.20 7.06 12.35
High Price
— — — — 202 264 313 354 316 388
Employees
— — — 0 1 2 2 2 2 2
Revenue/Emp
— — — 110 263 420 506 546 556 631
Revenue
— — — 71.80% 72.30% 71.79% 70.07% 69.09% 67.61% 66.53%
Gross Margin
— — — 0 58 10 39 41 14 47
EBT
— — — 0.10% 22.07% 2.35% 7.66% 7.48% 2.58% 7.48%
EBT Margin
— 0 — 0 50 (10) 21 23 3 34
Net Income
— — — 1 1 1 2 1 0 5
Depreciation
— — — 0.72 1.72 2.64 3.06 3.25 3.28 3.86
Revenue/Sh
— — — 0.00 0.32 (0.06) 0.13 0.13 0.02 0.21
Earnings/Sh
— — — 0.04 0.14 0.42 (0.21) 0.60 0.48 0.37
Cash Flow/Sh
— — — (0.03) (0.01) (0.02) (0.03) (0.10) (0.10) (0.05)
Capex/Sh
— — — 0.01 0.13 0.40 (0.25) 0.50 0.38 0.32
Free CF/Sh
— — — 0.25 0.64 1.54 1.86 2.24 2.23 2.68
Book Value/Sh
— — — 153 153 159 165 168 169 163
Shares
— — — 80.81 80.81 0.00 60.42 47.79 375.15 56.97
PE Ratio
— — — 14.58 14.58 10.46 2.37 2.06 1.89 2.94
PS Ratio
— — — 40.59 40.59 17.86 3.89 2.98 2.78 4.24
PB Ratio
— — — 14.34 14.34 9.98 2.05 1.61 1.44 2.47
EV/Sales
— — — 123.83 123.83 65.74 (25.53) 10.38 12.51 29.36
EV/FCF
— — — 7 22 66 (35) 101 81 61
Op' Cash Flow
— — — (5) (2) (3) (5) (16) (17) (8)
Capex
— — — 2 19 64 (41) 85 64 53
FCF
— — — 36 88 231 285 328 293 357
Working Cap'
— — — — — — 19 — — —
Total Debt
— — — (38) (58) (197) (160) (247) (245) (301)
Net Debt
— — — 39 98 246 308 377 377 437
Sh' Equity
— — — 0.36% 50.66% (4.29%) 5.99% 5.21% 0.55% 6.29%
ROA
— — — (47.04%) 91.58% 14.26% 15.91% 16.35% 1.07% 17.45%
ROIC
— — — 0.16% 72.91% (5.57%) 7.66% 6.61% 0.72% 8.41%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

FIGS, Inc. peers in Apparel Manufacturing

All 23 Apparel Manufacturing stocks →

FIGS, Inc. (FIGS) key facts

  • FIGS, Inc. (FIGS) is an Apparel Manufacturing company in the Consumer Cyclical sector, listed on the New York Stock Exchange.
  • FIGS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $631.1 million, up 13.6% from fiscal 2024.
  • Net income was $34.3 million, or $0.21 per share (basic), a net margin of 5.43%.
  • As of September 25, 2026, FIGS traded at $13.42, a market capitalization of $2.1 billion.
  • At that price the stock trades at 36.3× trailing-twelve-month earnings and 3.1× sales.
  • Return on equity was 8.41% and debt-to-equity 0.00.

Source: company filings (standardised) and stockrow calculations.

FIGS, Inc. (FIGS) Latest News

News by impact score

Fine-tune

22 Sep

4

Five Below is strengthening its customer-focused model via digital engagement, social-led marketing and an evolving omnichannel platform to connect online discovery with store visits, targeting Gen Alpha and Gen Z. Management says these capabilities fuel its merchandising-marketing-store flywheel and align with strong operating momentum. In fiscal Q2, net sales rose 22.9% year over year to $1.26 billion, and comps rose 14.1%, driven by a ~13.6% gain in transactions and a 0.4% rise in average transaction value. The company shifted working-media spending from traditional ads to social channels, reporting encouraging results from connected TV and YouTube campaigns and stronger signals from social listening. It is early in capturing checkout data and using email broadly; planned investments in personalization could improve retention and lifetime value and enhance site/app experiences. Full-year guidance was raised to net sales of $5.63-$5.71B, comps of 10-12%, and adjusted EPS of $9.83-$10.31. Digital marketing shift and stronger 2026 guidance imply meaningful upside but depend on converting online attention into repeat visits.

18 Sep

4

Brinker sets FY29 targets and plans faster unit expansion. Faster unit expansion and FY29 targets represent major strategic growth moves that can significantly shift company trajectory.

2 Sep

3

FIGS reports accelerating growth in international operations driven by robust worldwide demand. International momentum on global demand supports revenue expansion and market positioning.

20 Aug

3

FIGS customer base expands with strengthened repeat engagement. Customer base growth and repeat engagement support FIGS financial performance.

18 Aug

4

FIGS Inc. shows strong positioning that could drive a notable stock surge based on current fundamentals and market signals. Bullish outlook on strategic positioning points to significant effects on future performance and investor sentiment.

15 Aug

3

FIGS Q2 earnings show revenue growth amid margin pressure, leading to a hold recommendation as competition in medical apparel intensifies and valuation limits upside. Q2 results point to steady operations without transformative changes to competitive standing or long-term growth outlook.

3

FIGS Inc. fielded five key analyst questions during its Q2 earnings call, covering operational and market topics. Earnings call questions can highlight investor concerns that moderately affect near-term stock sentiment.

14 Aug

4

Wolverine stock rose 10% after Q2 earnings beat and raised 2026 outlook. Q2 earnings beat with raised 2026 outlook signals stronger performance and growth prospects.

13 Aug

4

FIGS raised 2026 guidance and expanded buybacks, driving a 32% stock increase. The move prompts questions on whether the bull case has shifted. Guidance raise plus larger buybacks represent major strategic actions that can shift financial trajectory and investor sentiment.

3 transcript

FIGS, Inc. held its Q2 2026 earnings call, covering revenue, margins, operational updates, and forward guidance for the apparel business. Quarterly earnings data and guidance directly inform near-term financial expectations and investor positioning for the stock.

11 Aug

4

FIGS raised its 2026 outlook citing accelerating revenue growth and margins. Raising the 2026 outlook on accelerating revenue growth and margins signals stronger future financial performance and positive shifts in market positioning.

4

FIGS posts broad-based Q2 growth driven by supply chain agility and category expansion. Broad-based growth, supply chain agility, and category expansion point to major operational gains that can materially lift future performance and investor views.

3

FIGS shares rose 25% over three months on expanding growth, margins and building momentum. Improving growth margins and momentum support moderate positive effects on future performance and sentiment.

10 Aug

3

FIGS shares surge on positive developments boosting investor sentiment and trading volume. Short-term stock movement from company-specific news may lift sentiment without altering long-term fundamentals.

3

FIGS stock continues rising amid sustained sales growth, expanding market presence and favorable investor sentiment toward the apparel brand. Stock appreciation signals positive momentum yet provides no indication of major strategic or regulatory shifts altering long-term trajectory.

9 Aug

3

FIGS posts strong earnings and raises its outlook, but the stock may now be fully valued. Strong earnings and raised guidance moderately affect valuation views and near-term trajectory.

8 Aug

3 transcript

FIGS Q2 earnings call highlighted revenue growth, margin trends, product expansion and guidance updates for the medical apparel company. Q2 earnings details and guidance directly affect near-term financial outlook and investor sentiment for FIGS.

7 Aug

4

FIGS shares jumped after the company posted strong second-quarter results and raised its 2026 outlook. Strong quarterly results and raised 2026 outlook directly improve financial trajectory and investor sentiment.

4 transcript

FIGS, Inc. conducted its Q2 2026 earnings call, covering quarterly financial results, operational updates, and forward-looking guidance. Quarterly earnings calls deliver financial metrics and strategy details that drive immediate stock movement and valuation shifts.

6 Aug

4

FIGS reported impressive Q2 CY2026 earnings, driving a 25.1% stock surge. Strong quarterly results and sharp stock gain signal meaningful shifts in financial trajectory and investor outlook.

3

FIGS, Inc. reported Q2 earnings and revenues that exceeded analyst estimates. Q2 earnings beat signals stronger financial results with noticeable but non-transformative effect on performance and sentiment.

3

FIGS Q2 earnings feature key metrics compared to analyst estimates. Q2 metrics versus estimates offer moderate insight into financial performance without indicating major strategic shifts.

3

FIGS, Inc. released its second quarter 2026 financial results. Quarterly earnings releases deliver performance data that can shift investor views and near-term stock movement.

15 Jul

3

FIGS upgraded to Buy rating by analysts, signaling improved outlook and potential positive momentum for the stock. Buy upgrade may lift short-term sentiment and trading activity without altering core operations or long-term trajectory.

30 Jun

3

FIGS stock outlook depends on scrubs sales growth and international expansion efforts. Scrubs growth and global expansion can moderately influence FIGS financial performance and positioning.

10 Jun

3

FIGS exceeded profitability expectations, potentially shifting the prior bullish case for the stock. Profitability beat exceeding expectations points to stronger financial results that could moderately sway investor views.

20 May

4

FIGS posts strong Q1 results that challenge market sentiment while lifting its growth outlook. Strong Q1 beat plus raised growth outlook signals material upside for revenue trajectory and investor sentiment.

17 May

3

FIGS posted strong Q1 revenue growth yet markets remain focused on doubts over whether the gains can be sustained long term. Q1 revenue strength is offset by sustainability concerns that may weigh on near-term investor sentiment and valuation without altering core operations.

3

FIGS faced analyst questions in its Q1 earnings call on revenue growth drivers, margin expansion, international expansion, inventory management, and customer acquisition costs in the medical apparel market. Analyst questions expose focus on operational and competitive issues likely to influence FIGS near-term results without signaling major strategic shifts.

10 May

3

FIGS Inc. released Q1 earnings call highlights detailing financial results, revenue growth, profitability metrics, strategic initiatives, and forward guidance amid competitive apparel market dynamics. Q1 earnings highlights provide key financial metrics and outlook that moderately influence FIGS' short-term performance and investor sentiment.

stockrow.com/FIGS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com